Sales Medical Device
Resume:
Bryan Bennett
Email: *********@********.***
Address: **** ********* *****
City: Yardley
State: PA
Zip: 19067
Country: USA
Phone: 215-***-****
Skill Level: Experienced
Salary Range: $160,000
Primary Skills/Experience:
See Resume
Educational Background:
See Resume
Job History / Details:
BRYAN T. BENNETT
1209 Goldenrod Court
Yardley, PA 19067
*********@********.***
LEGAL EXPERIENCE
DUANE MORRIS LLP, Philadelphia, PA
Special Counsel, March 2012 until January 2013
. Represent clients in all aspects of their legal business, including
compliance issues; corporate finance, mergers and acquisitions and other
strategic business transactions; the negotiation of various contracts,
including licensing, sales, supply, services, distribution, lease,
consulting, advisory, employment, transition services, manufacturing,
confidentiality and non-disclosure agreements; and corporate governance
issues, including board governance practices and procedures, board
composition, compensation, and management succession and continuity.
EPOCRATES, INc., Ewing, NJ
Assistant General Counsel, September 2011 until March 2012
. Managed every aspect of contracts and legal transactions, including daily
interaction with the Chief Executive Officer, General Counsel, Chief
Financial Officer, outside counsels and over 30 sales representatives.
Dechert LLP, Philadelphia, PA
Corporate and Securities Associate, Summer of 2003 (Summer Associate),
September 2004 until September 2011
. Represented clients in connection with various corporate finance, mergers
and acquisitions and other strategic business transactions.
. Negotiated, drafted and reviewed various types of contracts, including
licensing, sales, supply, services, distribution, lease, consulting,
advisory, employment, transition services, manufacturing, confidentiality
and non-disclosure agreements.
. Represented strategic buyers and sellers as well as private equity
sponsors and their portfolio companies in mergers and acquisitions
transactions, including negotiating and drafting the appropriate sale and
purchase agreements and other related documents.
. Advised clients on a wide range of corporate governance issues, including
board governance practices and procedures, board composition,
compensation, management succession and continuity, and management
evaluation.
. Advised clients across a broad range of industries regarding public
company reporting issues, including compliance with disclosure and other
obligations under the federal securities laws and applicable listing
requirements, and preparing and filing various SEC compliance items such
as Form 3s, 4s and 5s, 8-Ks, 10-Qs, 10-Ks, Annual Proxy Statements, etc.
. Represented issuers and underwriters in connection with both public and
private equity and debt financings, including drafting and reviewing the
relevant offering documents, preparing and submitting the listing
applications to the applicable securities exchange, assembling deal teams
in multiple specialties (tax, intellectual property, employee benefits,
labor, real property, environmental, etc.), and leading these teams in
completing the transaction.
EDUCATION
Harvard Law School, Cambridge, MA
Cum Laude, May 2004
Honors and activities: Member of Law and Economics Journal
Temple University, Philadelphia, PA
Dual degrees in Finance and Economics
Summa Cum Laude, May 2001
Honors and activities: Graduated 1st in class of 1,638 with a
perfect 4.0 grade point average.
BRYAN T. BENNETT
Representative Transactions
Representative M&A transactions include:
Select Medical Corporation ("Select"), a NYSE-listed specialized
provider of both inpatient and outpatient health care, in its $100 million
acquisition of SemperCare, Inc., a Texas-based operator of health care
facilities;
MWI Veterinary Supply, Inc. ("MWI"), a NASDAQ-listed distributor of
pharmaceutical products for animals, in its $47 million acquisition of
Centaur Services Limited, a provider of veterinary medicinal supplies
located in the United Kingdom;
Power Medical Interventions, Inc., a medical device provider and
former NASDAQ-listed company, in its $65 million sale to Covidien plc
through a merger of PMI with and into Covidien Delaware Corp.;
Court Square Capital Partners and Weston Presidio in their $1.3
billion acquisition of publicly-traded MacDermid Incorporated, a specialty
chemical company;
Crown Holdings, Inc. in its $750 million sale of Crown's plastic
closures business to Paris-based PAI Partners, which involved 29 plants in
15 countries;
CDI Corporation in its $40 million sale of Today's Staffing, Inc. to
Spherion Corporation;
Intellon Corporation, a NASDAQ-listed semiconductor company, in its
$244 million stock-and-cash merger with Atheros Communications, Inc.; and
RAF Industries, Inc. in its acquisitions of numerous portfolio
companies, including Weldship Industries, Marblecrafters, Inc., Pine
Environmental Services, Inc., Steamaster Co., Milspray LLC and Earth Tech,
Inc.
Representative Securities transactions include:
Drafting, reviewing and/or filing of all SEC compliance documents,
including Form 3s, Form 4s, 8-Ks, 10-Qs, 10-Ks, etc., including the
preparation of an internal beneficial ownership memorandum and summary;
and drafting all corporate governance documents, including Insider Trading
Policy, Code of Conduct, Code of Ethics and Committee Charters;
J.P. Morgan Securities ("J.P. Morgan") as underwriter in the $65.7
million secondary offering by Savient Pharmaceuticals, Inc., a specialty
biopharmaceutical and NASDAQ-listed company;
J.P. Morgan as placement agent in the $33.8 million and $23.9 million
registered direct offerings by Neose Technologies, Inc., a clinical stage
biopharmaceutical company;
Boenning & Scattergood as placement agent in the $50 million
registered direct offering by Oncothyreon, Inc., a biotechnology and
NASDAQ-listed company;
B&G Foods in its registered public offering of $350 million of its
7.625% Senior Notes due 2018;
Select in its $300 million initial public offering;
MWI in its $73.6 million initial public offering;
Seitel, Inc. in its offer to exchange $400,000,000 of its 9 3/4%
Senior Notes Due 2014 for $400,000,000 of its 9 3/4% Senior Notes Due
2014; and
Edgen Murray corporation in its 144A high yield private placement of
$465 million of its 12.25% Senior Secured Notes due 2015 and related
exchange offer.
Contact this candidate